My Quote Request
6505-01-492-5820
20 Products
NDC58160-0856-56
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014925820
NSN
6505-01-492-5820
NDC58160-0856-56
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014925820
NSN
6505-01-492-5820
MFG
GLAXO WELLCOME INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPATITIS B VIRUS VACCINE INACTIVATED 10MCG/0.5ML SYRINGE 25S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C
III SUPPLEMENTARY FEATURES: SINGLE-DOSE PRE-FILLED DISPOSABLE TIP-LOK SYRINGES WITH 1-INCH 23-GAUGE NEEDLES
IMMEDIATE CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: RECOMBINANT; PEDIATRIC/ADOLESCENT; EACH 0.5 ML OF VACCINE CONSISTS OF 10 MCG OF HEPATITIS B SURFACE ANTIGEN ADSORBED ON 0.25 MG ALUMINUM AS ALUMINUM HYDROXIDE; IS FORMULATED WITHOUT PERSERVATIVES; SUPPLIED AS A STERILE SUSPENSION FOR INTRAMUSCULAR
UNIT PACKAGE QUANTITY: 25
UNIT PACKAGE TYPE: PACKAGE
~1: ADMINISTRATION; READY FOR USE WITHOUT RECONSTITUTION. DO NOT FREEZE, DICARD IF PRODUCT HAS BEEN FROZEN. DO NOT DILUTE TO ADMINISTER
Related Searches:
ENGERIX-B
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014925820
NSN
6505-01-492-5820
ENGERIX-B
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014925820
NSN
6505-01-492-5820
MFG
GLAXO WELLCOME INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPATITIS B VIRUS VACCINE INACTIVATED 10MCG/0.5ML SYRINGE 25S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C
III SUPPLEMENTARY FEATURES: SINGLE-DOSE PRE-FILLED DISPOSABLE TIP-LOK SYRINGES WITH 1-INCH 23-GAUGE NEEDLES
IMMEDIATE CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: RECOMBINANT; PEDIATRIC/ADOLESCENT; EACH 0.5 ML OF VACCINE CONSISTS OF 10 MCG OF HEPATITIS B SURFACE ANTIGEN ADSORBED ON 0.25 MG ALUMINUM AS ALUMINUM HYDROXIDE; IS FORMULATED WITHOUT PERSERVATIVES; SUPPLIED AS A STERILE SUSPENSION FOR INTRAMUSCULAR
UNIT PACKAGE QUANTITY: 25
UNIT PACKAGE TYPE: PACKAGE
~1: ADMINISTRATION; READY FOR USE WITHOUT RECONSTITUTION. DO NOT FREEZE, DICARD IF PRODUCT HAS BEEN FROZEN. DO NOT DILUTE TO ADMINISTER
Related Searches:
ENGERIX-B
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014925821
NSN
6505-01-492-5821
ENGERIX-B
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014925821
NSN
6505-01-492-5821
MFG
GLAXO WELLCOME INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPATITIS B VIRUS VACCINE INACTIVATED 10MCG/0.25MG VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C
IMMEDIATE CONTAINER TYPE: VIAL
SPECIAL FEATURES: RECOMBINANT; PEDIATRIC/ADOLESCENT; EACH 0.5 ML OF VACCINE CONSISTS OF 10 MCG OF HEPATITIS B SURFACE ANTIGEN ADSORBED ON 0.25 MG ALUMINUM AS ALUMINUM HYDROXIDE.THE VACCINE IS FORMULATED WITHOUT PRESERVATIVES; IS SUPPLIED AS A STERILE SUSPENSION FOR
UNIT PACKAGE QUANTITY: 10
UNIT PACKAGE TYPE: PACKAGE
~1: INTRAMUSCULAR ADMINISTRATION,IS READY FOR USE WITHOUT RECONSTITUTION. DO NOT FREEZE, DISCARD IF PRODUCT HAS BEEN FROZEN. DO NOT DILUTE TO ADMINISTER
Related Searches:
NDC58160-0820-11
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014925821
NSN
6505-01-492-5821
NDC58160-0820-11
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014925821
NSN
6505-01-492-5821
MFG
GLAXO WELLCOME INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPATITIS B VIRUS VACCINE INACTIVATED 10MCG/0.25MG VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C
IMMEDIATE CONTAINER TYPE: VIAL
SPECIAL FEATURES: RECOMBINANT; PEDIATRIC/ADOLESCENT; EACH 0.5 ML OF VACCINE CONSISTS OF 10 MCG OF HEPATITIS B SURFACE ANTIGEN ADSORBED ON 0.25 MG ALUMINUM AS ALUMINUM HYDROXIDE.THE VACCINE IS FORMULATED WITHOUT PRESERVATIVES; IS SUPPLIED AS A STERILE SUSPENSION FOR
UNIT PACKAGE QUANTITY: 10
UNIT PACKAGE TYPE: PACKAGE
~1: INTRAMUSCULAR ADMINISTRATION,IS READY FOR USE WITHOUT RECONSTITUTION. DO NOT FREEZE, DISCARD IF PRODUCT HAS BEEN FROZEN. DO NOT DILUTE TO ADMINISTER
Related Searches:
04-0878
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505014925896
NSN
6505-01-492-5896
04-0878
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505014925896
NSN
6505-01-492-5896
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
FEATURES PROVIDED: DILUENT AND STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION USP 125MG POWDER VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00009-0190-16
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505014925896
NSN
6505-01-492-5896
NDC00009-0190-16
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505014925896
NSN
6505-01-492-5896
MFG
VETERANS HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
FEATURES PROVIDED: DILUENT AND STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION USP 125MG POWDER VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
SOLU-MEDROL
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505014925896
NSN
6505-01-492-5896
SOLU-MEDROL
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505014925896
NSN
6505-01-492-5896
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
FEATURES PROVIDED: DILUENT AND STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION USP 125MG POWDER VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
01-0652
DEXAMETHASONE SODIUM PHOSPHATE INJECTION,USP
NSN, MFG P/N
6505014926420
NSN
6505-01-492-6420
01-0652
DEXAMETHASONE SODIUM PHOSPHATE INJECTION,USP
NSN, MFG P/N
6505014926420
NSN
6505-01-492-6420
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS DEXAMETHASONE SODIUM PHOSPHATE PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR INTRAMUSCULAR OR INTRA-ARTICULAR OR INTRALESIONAL OR SOFT TISSUE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXAMETHASONE INJ 4MG/ML, 5ML VIAL, 25 VIAL/PACKAGE
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: STORE AT CONTROLLED ROOM TEMP 15 TO 30 DEG C; SENSITIVE TO HEAT, DO NOT AUTOCLAVE USE PREFERRED JDF NSN 6505015225164
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00517-4905-25
DEXAMETHASONE SODIUM PHOSPHATE INJECTION,USP
NSN, MFG P/N
6505014926420
NSN
6505-01-492-6420
NDC00517-4905-25
DEXAMETHASONE SODIUM PHOSPHATE INJECTION,USP
NSN, MFG P/N
6505014926420
NSN
6505-01-492-6420
MFG
LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS DEXAMETHASONE SODIUM PHOSPHATE PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR INTRAMUSCULAR OR INTRA-ARTICULAR OR INTRALESIONAL OR SOFT TISSUE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXAMETHASONE INJ 4MG/ML, 5ML VIAL, 25 VIAL/PACKAGE
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: STORE AT CONTROLLED ROOM TEMP 15 TO 30 DEG C; SENSITIVE TO HEAT, DO NOT AUTOCLAVE USE PREFERRED JDF NSN 6505015225164
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
01-0683
DOXYCYCLINE MONOHYDRATE FOR ORAL SUSPENSION
NSN, MFG P/N
6505014926461
NSN
6505-01-492-6461
01-0683
DOXYCYCLINE MONOHYDRATE FOR ORAL SUSPENSION
NSN, MFG P/N
6505014926461
NSN
6505-01-492-6461
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ADMINISTRATION: ORAL
FLAVOR: RASPBERRY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOXYCYCLINE MONOHYDRATE FOR ORAL SUSPENSION 25MG PER 60ML POWDER BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 20.500 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 25 MG OF DOXYCYCLINE PER 5 ML; CONTAINS 60 ML AFTER RECONSTITUTION OF DRY POWDER FOR ORAL SUSPENSION; PEDIATRIC; STORE BELOW 86 DEG F; DISPENSED IN TIGHT, LIGHT RESISTANT CONTAINERS
Related Searches:
NDC00069-0970-65
DOXYCYCLINE MONOHYDRATE FOR ORAL SUSPENSION
NSN, MFG P/N
6505014926461
NSN
6505-01-492-6461
NDC00069-0970-65
DOXYCYCLINE MONOHYDRATE FOR ORAL SUSPENSION
NSN, MFG P/N
6505014926461
NSN
6505-01-492-6461
MFG
PFIZER INC. DBA PFIZER
Description
ADMINISTRATION: ORAL
FLAVOR: RASPBERRY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOXYCYCLINE MONOHYDRATE FOR ORAL SUSPENSION 25MG PER 60ML POWDER BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 20.500 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 25 MG OF DOXYCYCLINE PER 5 ML; CONTAINS 60 ML AFTER RECONSTITUTION OF DRY POWDER FOR ORAL SUSPENSION; PEDIATRIC; STORE BELOW 86 DEG F; DISPENSED IN TIGHT, LIGHT RESISTANT CONTAINERS
Related Searches:
VIBRAMYCIN
DOXYCYCLINE MONOHYDRATE FOR ORAL SUSPENSION
NSN, MFG P/N
6505014926461
NSN
6505-01-492-6461
VIBRAMYCIN
DOXYCYCLINE MONOHYDRATE FOR ORAL SUSPENSION
NSN, MFG P/N
6505014926461
NSN
6505-01-492-6461
MFG
PFIZER INC. DBA PFIZER
Description
ADMINISTRATION: ORAL
FLAVOR: RASPBERRY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOXYCYCLINE MONOHYDRATE FOR ORAL SUSPENSION 25MG PER 60ML POWDER BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 20.500 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 25 MG OF DOXYCYCLINE PER 5 ML; CONTAINS 60 ML AFTER RECONSTITUTION OF DRY POWDER FOR ORAL SUSPENSION; PEDIATRIC; STORE BELOW 86 DEG F; DISPENSED IN TIGHT, LIGHT RESISTANT CONTAINERS
Related Searches:
01-0656
HAEMOPHILUS B POLYSACCHARIDE CONJUGATE (DIPHTHERIA TOXOID CONJUGATE) VACCINE
NSN, MFG P/N
6505014926474
NSN
6505-01-492-6474
01-0656
HAEMOPHILUS B POLYSACCHARIDE CONJUGATE (DIPHTHERIA TOXOID CONJUGATE) VACCINE
NSN, MFG P/N
6505014926474
NSN
6505-01-492-6474
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HAEMOPHILUS B POLYSACCHARIDE CONJUGATE VACCINE 0.6ML/DILUENT VIAL 5S
IMMEDIATE CONTAINER QUANTITY: 5
IMMEDIATE CONTAINER TYPE: VIAL
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 1 SINGLE DOSE WITH 0.6 ML VIAL CONTAINING DILUENT
SPECIAL FEATURES: STERILE, LYOPHILIZED POWDER RECONSTITUTED AT TIME OF USE WITH EITHER SALINE DILUENT (0.4% SODIUM CHLORIDE) OR AVENTIS PASTEUR INC DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE ADSORBED FOR INTRAMUSCULAR USE ONLY CONTAINS NO PRESERVATIVE; CONSISTS
UNIT PACKAGE TYPE: PACKAGE
~1: OF THE HAEMOPHILUS B CAPSULAR POLYSACCHARIDE PREPARED FROM THE H. INFLUENZAE TYPE B STRAIN 1482 AND COVALENTLY BOUND TO TETANUS TOXOID
Related Searches:
ACTHIB W/0.4% NACL DILUENT
HAEMOPHILUS B POLYSACCHARIDE CONJUGATE (DIPHTHERIA TOXOID CONJUGATE) VACCINE
NSN, MFG P/N
6505014926474
NSN
6505-01-492-6474
ACTHIB W/0.4% NACL DILUENT
HAEMOPHILUS B POLYSACCHARIDE CONJUGATE (DIPHTHERIA TOXOID CONJUGATE) VACCINE
NSN, MFG P/N
6505014926474
NSN
6505-01-492-6474
MFG
SANOFI PASTEUR INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HAEMOPHILUS B POLYSACCHARIDE CONJUGATE VACCINE 0.6ML/DILUENT VIAL 5S
IMMEDIATE CONTAINER QUANTITY: 5
IMMEDIATE CONTAINER TYPE: VIAL
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 1 SINGLE DOSE WITH 0.6 ML VIAL CONTAINING DILUENT
SPECIAL FEATURES: STERILE, LYOPHILIZED POWDER RECONSTITUTED AT TIME OF USE WITH EITHER SALINE DILUENT (0.4% SODIUM CHLORIDE) OR AVENTIS PASTEUR INC DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE ADSORBED FOR INTRAMUSCULAR USE ONLY CONTAINS NO PRESERVATIVE; CONSISTS
UNIT PACKAGE TYPE: PACKAGE
~1: OF THE HAEMOPHILUS B CAPSULAR POLYSACCHARIDE PREPARED FROM THE H. INFLUENZAE TYPE B STRAIN 1482 AND COVALENTLY BOUND TO TETANUS TOXOID
Related Searches:
NDC49281-0545-05
HAEMOPHILUS B POLYSACCHARIDE CONJUGATE (DIPHTHERIA TOXOID CONJUGATE) VACCINE
NSN, MFG P/N
6505014926474
NSN
6505-01-492-6474
NDC49281-0545-05
HAEMOPHILUS B POLYSACCHARIDE CONJUGATE (DIPHTHERIA TOXOID CONJUGATE) VACCINE
NSN, MFG P/N
6505014926474
NSN
6505-01-492-6474
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HAEMOPHILUS B POLYSACCHARIDE CONJUGATE VACCINE 0.6ML/DILUENT VIAL 5S
IMMEDIATE CONTAINER QUANTITY: 5
IMMEDIATE CONTAINER TYPE: VIAL
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 1 SINGLE DOSE WITH 0.6 ML VIAL CONTAINING DILUENT
SPECIAL FEATURES: STERILE, LYOPHILIZED POWDER RECONSTITUTED AT TIME OF USE WITH EITHER SALINE DILUENT (0.4% SODIUM CHLORIDE) OR AVENTIS PASTEUR INC DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE ADSORBED FOR INTRAMUSCULAR USE ONLY CONTAINS NO PRESERVATIVE; CONSISTS
UNIT PACKAGE TYPE: PACKAGE
~1: OF THE HAEMOPHILUS B CAPSULAR POLYSACCHARIDE PREPARED FROM THE H. INFLUENZAE TYPE B STRAIN 1482 AND COVALENTLY BOUND TO TETANUS TOXOID
Related Searches:
01-0692
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014926608
NSN
6505-01-492-6608
01-0692
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014926608
NSN
6505-01-492-6608
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPATITIS B VIRUS VACCINE INACTIVATED 10MCG/0.5ML SYRINGE 25S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C
III SUPPLEMENTARY FEATURES: SINGLE-DOSE PREFILLED DISPOSABLE TIP-LOK SYRINGES WITH 5/8-INCH 25-GAUGE SAFETYGLIDE NEEDLES
IMMEDIATE CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: RECOMBINANT; PEDIATRIC/ADOLESCENT; EACH 0.5 ML OF VACCINE CONSISTS OF 10 MCG OF HEPATITIS B SURFACE ANTIGEN ADSORBED ON 0.25 MG ALUMINUM AS ALUMINUM HYDROXIDE; IS FORMULATED WITHOUT PERSERVATIVES; SUPPLIED AS A STERILE SUSPENSION FOR INTRAMUSCULAR
UNIT PACKAGE QUANTITY: 25
UNIT PACKAGE TYPE: PACKAGE
~1: ADMINISTRATION; READY FOR USE WITHOUT RECONSTITUTION. DO NOT FREEZE, DISCARD IF PRODUCT HAS BEEN FROZEN. DO NOT DILUTE TO ADMINISTER
Related Searches:
ENGERIX-B
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014926608
NSN
6505-01-492-6608
ENGERIX-B
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014926608
NSN
6505-01-492-6608
MFG
SMITH KLINE BEECHMAN PHARMACEUTICALS
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPATITIS B VIRUS VACCINE INACTIVATED 10MCG/0.5ML SYRINGE 25S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C
III SUPPLEMENTARY FEATURES: SINGLE-DOSE PREFILLED DISPOSABLE TIP-LOK SYRINGES WITH 5/8-INCH 25-GAUGE SAFETYGLIDE NEEDLES
IMMEDIATE CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: RECOMBINANT; PEDIATRIC/ADOLESCENT; EACH 0.5 ML OF VACCINE CONSISTS OF 10 MCG OF HEPATITIS B SURFACE ANTIGEN ADSORBED ON 0.25 MG ALUMINUM AS ALUMINUM HYDROXIDE; IS FORMULATED WITHOUT PERSERVATIVES; SUPPLIED AS A STERILE SUSPENSION FOR INTRAMUSCULAR
UNIT PACKAGE QUANTITY: 25
UNIT PACKAGE TYPE: PACKAGE
~1: ADMINISTRATION; READY FOR USE WITHOUT RECONSTITUTION. DO NOT FREEZE, DISCARD IF PRODUCT HAS BEEN FROZEN. DO NOT DILUTE TO ADMINISTER
Related Searches:
NDC58160-0856-57
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014926608
NSN
6505-01-492-6608
NDC58160-0856-57
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014926608
NSN
6505-01-492-6608
MFG
SMITH KLINE BEECHMAN PHARMACEUTICALS
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPATITIS B VIRUS VACCINE INACTIVATED 10MCG/0.5ML SYRINGE 25S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C
III SUPPLEMENTARY FEATURES: SINGLE-DOSE PREFILLED DISPOSABLE TIP-LOK SYRINGES WITH 5/8-INCH 25-GAUGE SAFETYGLIDE NEEDLES
IMMEDIATE CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: RECOMBINANT; PEDIATRIC/ADOLESCENT; EACH 0.5 ML OF VACCINE CONSISTS OF 10 MCG OF HEPATITIS B SURFACE ANTIGEN ADSORBED ON 0.25 MG ALUMINUM AS ALUMINUM HYDROXIDE; IS FORMULATED WITHOUT PERSERVATIVES; SUPPLIED AS A STERILE SUSPENSION FOR INTRAMUSCULAR
UNIT PACKAGE QUANTITY: 25
UNIT PACKAGE TYPE: PACKAGE
~1: ADMINISTRATION; READY FOR USE WITHOUT RECONSTITUTION. DO NOT FREEZE, DISCARD IF PRODUCT HAS BEEN FROZEN. DO NOT DILUTE TO ADMINISTER
Related Searches:
ICT MALARIA TEST
MALARIA TEST
NSN, MFG P/N
6505014926996
NSN
6505-01-492-6996
MFG
BINAX INC DBA INVERNESS MEDICAL PROFESSIONAL DIAGNOSTICS
Description
MALARIA TEST
Related Searches:
01-0682
CIPROFLOXACIN ORAL
NSN, MFG P/N
6505014928089
NSN
6505-01-492-8089
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN SUSPENSION 250MG/5ML 100ML AFTER RECONSTITUTION
SPECIAL FEATURES: CIPROFLOXACIN MICROENCAPSULATED; 250 MG PER 5 ML, 100 ML AFTER RECONSTITUTION, ORAL SUSPENSION; THE DRUG IS COMPOSED OF TWO COMPONENTS (MICROCAPSULES AND DILUENT); STORE BELOW 25 DEGREES C (77 DEGREES F) PROTECT FROM FREEZING